Direct Flow Medical gets 5th patent related to PAV tech

May 2009
Medical Device Daily;5/26/2009, Vol. 13 Issue 99, p5
This article reports on the fifth patent received by emerging device company Direct Flow Medical (DFM) for its Percutaneous Aortic Valve (PAV) technology. The PAV system enables the physician to assess the hemodynamic outcomes prior to final deployment of the device. DFM President and Chief Executive Officer (CEO) Bernard Lyons points out the unique design features of the device. The company has received three new patents in 2008.


Related Articles

  • United Kingdom : DIRECT Flow Medical heart valve device secures authorization in Europe.  // TendersInfo News;8/23/2014, p1 

    The article informs that Direct Flow Medical has secured the European regulatory sanction of an aortic valve system. Topics discussed include Direct Flow Medical to sell its 23-milligram valve as well as other valve sizes and it comes as the company attempts to win the U.S. Food and Drug...

  • Direct Flow closes Series B, begins European valve trial.  // Medical Device Daily;10/26/2007, Vol. 11 Issue 206, p1 

    The article reports that Direct Flow Medical is completing its Series B financing and initiating clinical trials in Europe for a catheter-based system to replace the aortic valve in patients with valve disease as an option to open surgery. The system is an investigational device, an implantable...

  • OC Heart Valve Makers Call on Cardiology College. REED, VITA // Orange County Business Journal;3/18/2013, Vol. 36 Issue 11, p4 

    The article focuses on clinical trials performed by Edward Lifesciences Corp. on Sapien XT, a replacement aortic valve. It states that the data from clinical trial showed similar death and stroke rates and lower perforation and hematoma for patients with Edwards Sapien, a transcatheter heart...

  • Eleven years’ experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate Dellgren, Göran; Eriksson, M.J.; Brodin, L.Å.; Rådegran, K. // European Journal of Cardio-Thoracic Surgery;Dec2002, Vol. 22 Issue 6, p912 

    Objective. The long-term durability and hemodynamics of stentless valves are largely unknown. Our aim was to prospectively investigate long-term hemodynamic function and clinical outcome after aortic valve replacement with the Biocor stentless aortic bioprosthesis. Patients and methods. Between...

  • Post-surgical hemodynamics in aortic valve bypass (AVB) patients evaluated with phase contrast magnetic resonance (PCMR). Lam, Adrian; Clement-Guinaudeau, Stephanie; Padala, Muralidhar; Thourani, Vinod; Oshinski, John N. // Journal of Cardiovascular Magnetic Resonance (BioMed Central);2012 Supplement, Vol. 14 Issue Suppl 1, p1 

    An abstract of the conference paper "Post-surgical hemodynamics in aortic valve bypass (AVB) patients evaluated with phase contrast magnetic resonance (PCMR)," by Adrian Lam, and colleagues is presented.

  • Ruptured sinus of Valsalva aneurysm associated with aortic regurgitation caused by hemodynamic effect solely Maruo, Ayako; Higami, Tetsuya; Obo, Hidefumi; Shida, Tsutomu // European Journal of Cardio-Thoracic Surgery;Aug2003, Vol. 24 Issue 2, p318 

    We describe a case of ruptured sinus of Valsalva aneurysm (RSVA) with moderate aortic regurgitation (AR), which developed on the second day after admission. The AR was caused by a hemodynamic effect solely, in which the shunt blood flow through ruptured site pulled the right aortic cusp away...

  • Dynamic device properties of pulse contour cardiac output during transcatheter aortic valve implantation. Petzoldt, Martin; Riedel, Carsten; Braeunig, Jan; Haas, Sebastian; Goepfert, Matthias; Treede, Hendrik; Baldus, Stephan; Goetz, Alwin; Reuter, Daniel // Journal of Clinical Monitoring & Computing;Jun2015, Vol. 29 Issue 3, p323 

    This prospective single-center study aimed to determine the responsiveness and diagnostic performance of continuous cardiac output (CCO) monitors based on pulse contour analysis compared with invasive mean arterial pressure (MAP) during predefined periods of acute circulatory deterioration in...

  • The next medical device scandal: Medical device files - my personal view (Part 1).  // Medical Writing;Mar2019, Vol. 28 Issue 1, p86 

    A personal narrative is presented which explores the author's experience to increase public awareness to ensure a healthy and manageable dog population and also provide information on adopting dogs from abroad. It mentions a scandal on coronary stents that became worse than coronary bypass grafts.

  • Up to 16 years follow-up of aortic valve reconstruction with pericardium: a stentless readily available cheap valve? Halees, Zohair Al; Shahid, Maie Al; Sanei, Aly Al; Sallehuddin, Ahmed; Duran, Carlos // European Journal of Cardio-Thoracic Surgery;Aug2005, Vol. 28 Issue 2, p200 

    Abstract: Objective: There is lack of information regarding the long-term behavior of aortic valve reconstruction with pericardium (AoR). A 16-year follow-up is reported here. Methods: Between 1988 and 1995, 92 consecutive patients had AoR with bovine (Group I, n=27) or glutaraldehyde-treated...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics